Vladmir C. Cordeiro de Lima, Medical Oncologist at A C Camargo Cancer Center, shared an article by Erick F. Saldanha, et al. on X:
“Our paper describing the frequency and characteristics of ERBB2 mutations in Latin American NSCLC patients is out at The Oncologist!
Mutation rate 2.8% (mostly never smokers). rwOS-25.9 mo.
Congratulatios to Erick Saldanha, Andres F. Cardona and all CLICaP!”
Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP).
Authors: Erick F. Saldanha, et al.
